Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 35 | 2023 | 196 | 6.730 |
Why?
|
| Bacterial Vaccines | 20 | 2023 | 122 | 5.640 |
Why?
|
| Chlamydia trachomatis | 20 | 2019 | 66 | 4.130 |
Why?
|
| Chlamydia | 14 | 2023 | 42 | 3.130 |
Why?
|
| Vibrio cholerae | 14 | 2021 | 98 | 2.170 |
Why?
|
| Dendritic Cells | 10 | 2021 | 112 | 1.990 |
Why?
|
| Porins | 6 | 2019 | 18 | 1.920 |
Why?
|
| Chlamydia muridarum | 8 | 2021 | 104 | 1.680 |
Why?
|
| Mice | 37 | 2023 | 5668 | 1.210 |
Why?
|
| Th1 Cells | 11 | 2019 | 87 | 1.140 |
Why?
|
| Membrane Proteins | 4 | 2021 | 486 | 1.140 |
Why?
|
| Mice, Inbred C57BL | 23 | 2023 | 1530 | 1.120 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2017 | 50 | 1.100 |
Why?
|
| Bacterial Proteins | 5 | 2020 | 520 | 1.040 |
Why?
|
| Antibodies, Bacterial | 10 | 2019 | 107 | 1.020 |
Why?
|
| Immunity, Mucosal | 7 | 2021 | 45 | 1.020 |
Why?
|
| Chlamydophila psittaci | 2 | 2021 | 2 | 1.010 |
Why?
|
| Antigens, Bacterial | 8 | 2021 | 129 | 0.940 |
Why?
|
| Animals | 45 | 2023 | 14307 | 0.930 |
Why?
|
| Psittacosis | 2 | 2021 | 2 | 0.870 |
Why?
|
| Chitosan | 1 | 2021 | 36 | 0.790 |
Why?
|
| MicroRNAs | 4 | 2021 | 386 | 0.720 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 4 | 0.720 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 66 | 0.650 |
Why?
|
| Vaccines, Subunit | 7 | 2023 | 30 | 0.650 |
Why?
|
| Immunity, Innate | 3 | 2017 | 135 | 0.650 |
Why?
|
| Cholera | 3 | 2011 | 70 | 0.620 |
Why?
|
| Antigen Presentation | 5 | 2017 | 54 | 0.610 |
Why?
|
| Adjuvants, Immunologic | 6 | 2017 | 106 | 0.610 |
Why?
|
| Nanoparticles | 1 | 2021 | 294 | 0.590 |
Why?
|
| Signal Transduction | 5 | 2020 | 1802 | 0.580 |
Why?
|
| Female | 34 | 2023 | 19873 | 0.580 |
Why?
|
| Vaccines, Synthetic | 5 | 2010 | 72 | 0.480 |
Why?
|
| Immunologic Memory | 2 | 2011 | 38 | 0.420 |
Why?
|
| Vagina | 4 | 2023 | 81 | 0.410 |
Why?
|
| Drug Evaluation | 1 | 2011 | 9 | 0.410 |
Why?
|
| Cholera Toxin | 2 | 2008 | 34 | 0.400 |
Why?
|
| Trachoma | 1 | 2010 | 2 | 0.380 |
Why?
|
| Blindness | 1 | 2010 | 16 | 0.380 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 179 | 0.370 |
Why?
|
| Th2 Cells | 2 | 2020 | 56 | 0.360 |
Why?
|
| Interferon-gamma | 4 | 2021 | 235 | 0.350 |
Why?
|
| Immunoglobulin A | 3 | 2019 | 58 | 0.350 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2020 | 15 | 0.350 |
Why?
|
| Drug Delivery Systems | 4 | 2007 | 182 | 0.330 |
Why?
|
| Cholera Vaccines | 3 | 2007 | 18 | 0.330 |
Why?
|
| Genitalia | 2 | 2019 | 17 | 0.330 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 17 | 0.320 |
Why?
|
| Genetic Vectors | 5 | 2011 | 154 | 0.320 |
Why?
|
| Vaccination | 4 | 2021 | 259 | 0.320 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 9 | 0.310 |
Why?
|
| Hela Cells | 6 | 2018 | 344 | 0.310 |
Why?
|
| Viral Vaccines | 2 | 2006 | 28 | 0.310 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 20 | 0.300 |
Why?
|
| Herpes Genitalis | 1 | 2006 | 6 | 0.300 |
Why?
|
| Herpesvirus 2, Human | 1 | 2006 | 9 | 0.300 |
Why?
|
| Immunity, Cellular | 4 | 2017 | 68 | 0.290 |
Why?
|
| NF-kappa B | 2 | 2020 | 306 | 0.280 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 77 | 0.280 |
Why?
|
| Interleukin-10 | 5 | 2017 | 69 | 0.280 |
Why?
|
| Caspase 1 | 2 | 2017 | 15 | 0.280 |
Why?
|
| Vaccines, Combined | 3 | 2011 | 11 | 0.250 |
Why?
|
| Ruminants | 1 | 2023 | 6 | 0.240 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 48 | 0.230 |
Why?
|
| Chickens | 2 | 2021 | 123 | 0.230 |
Why?
|
| Fertility | 3 | 2015 | 59 | 0.230 |
Why?
|
| Humans | 21 | 2023 | 34853 | 0.230 |
Why?
|
| Pregnancy | 4 | 2023 | 1503 | 0.230 |
Why?
|
| Pelvic Inflammatory Disease | 2 | 2020 | 20 | 0.230 |
Why?
|
| Administration, Intranasal | 2 | 2021 | 77 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 1300 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 183 | 0.200 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 600 | 0.200 |
Why?
|
| Genital Diseases, Female | 4 | 2007 | 37 | 0.190 |
Why?
|
| Mice, Knockout | 10 | 2017 | 897 | 0.190 |
Why?
|
| Avian Proteins | 1 | 2020 | 4 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 58 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2013 | 232 | 0.190 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 25 | 0.190 |
Why?
|
| Lymphocyte Activation | 5 | 2014 | 222 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2009 | 84 | 0.180 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2019 | 5 | 0.180 |
Why?
|
| Infertility, Female | 2 | 2013 | 24 | 0.180 |
Why?
|
| Antibody Formation | 3 | 2011 | 73 | 0.180 |
Why?
|
| Spleen | 2 | 2010 | 192 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2017 | 1442 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 212 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2020 | 366 | 0.160 |
Why?
|
| Administration, Rectal | 1 | 2017 | 17 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.150 |
Why?
|
| Macrophages | 2 | 2020 | 431 | 0.150 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 210 | 0.150 |
Why?
|
| Cell Line | 5 | 2020 | 1289 | 0.150 |
Why?
|
| Fibrosis | 1 | 2017 | 146 | 0.150 |
Why?
|
| Vaccines, DNA | 3 | 2013 | 23 | 0.150 |
Why?
|
| Flow Cytometry | 1 | 2017 | 392 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 445 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 184 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2017 | 834 | 0.130 |
Why?
|
| Cytokines | 4 | 2017 | 569 | 0.130 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 23 | 0.130 |
Why?
|
| Proteomics | 3 | 2017 | 302 | 0.130 |
Why?
|
| Gram-Negative Bacteria | 2 | 2004 | 22 | 0.120 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 59 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 522 | 0.120 |
Why?
|
| Mucous Membrane | 3 | 2008 | 34 | 0.120 |
Why?
|
| Bacteriophage lambda | 1 | 2013 | 12 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 341 | 0.110 |
Why?
|
| Chlamydiaceae Infections | 1 | 2012 | 3 | 0.110 |
Why?
|
| Receptors, Fc | 2 | 2003 | 7 | 0.110 |
Why?
|
| Calcitriol | 1 | 2012 | 30 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2013 | 194 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 59 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 99 | 0.100 |
Why?
|
| Cross Protection | 1 | 2011 | 4 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2010 | 9 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2011 | 56 | 0.100 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 14 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 84 | 0.090 |
Why?
|
| Photoperiod | 2 | 2020 | 26 | 0.090 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2009 | 11 | 0.090 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 33 | 0.090 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 23 | 0.090 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 71 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2011 | 328 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1149 | 0.090 |
Why?
|
| Genomics | 1 | 2010 | 201 | 0.080 |
Why?
|
| Protozoan Vaccines | 2 | 2009 | 15 | 0.080 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2009 | 80 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 649 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 52 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2005 | 30 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2005 | 156 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2007 | 17 | 0.080 |
Why?
|
| Vero Cells | 1 | 2006 | 90 | 0.070 |
Why?
|
| Fibronectins | 2 | 2017 | 65 | 0.070 |
Why?
|
| Cadherins | 2 | 2017 | 82 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 968 | 0.070 |
Why?
|
| Inflammation | 2 | 2013 | 577 | 0.070 |
Why?
|
| Chemokines | 2 | 2003 | 89 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2017 | 423 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 23 | 0.060 |
Why?
|
| Fungal Vaccines | 1 | 2004 | 41 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 66 | 0.060 |
Why?
|
| Plasmids | 1 | 2004 | 233 | 0.060 |
Why?
|
| Apoptosis | 3 | 2017 | 1317 | 0.060 |
Why?
|
| Antibodies | 1 | 2004 | 135 | 0.060 |
Why?
|
| Intestines | 1 | 2003 | 63 | 0.060 |
Why?
|
| Chlamydophila | 1 | 2003 | 1 | 0.060 |
Why?
|
| Chlamydophila Infections | 1 | 2003 | 1 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 170 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 186 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 195 | 0.060 |
Why?
|
| Uterus | 1 | 2023 | 54 | 0.060 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.060 |
Why?
|
| Diarrhea | 1 | 2003 | 84 | 0.060 |
Why?
|
| Antigens | 1 | 2003 | 56 | 0.060 |
Why?
|
| Cell Wall | 1 | 2003 | 53 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 68 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 181 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 14 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 360 | 0.050 |
Why?
|
| Poultry Diseases | 1 | 2020 | 7 | 0.050 |
Why?
|
| Endocytosis | 1 | 2020 | 104 | 0.040 |
Why?
|
| Myosin Type II | 1 | 2018 | 18 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 639 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 151 | 0.040 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 2 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 24 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 18 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 49 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 16 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 68 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 3 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 14 | 0.040 |
Why?
|
| Actins | 1 | 2017 | 142 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 49 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2017 | 23 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 121 | 0.040 |
Why?
|
| Collagen | 1 | 2017 | 162 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 275 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 642 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 859 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 20 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2015 | 4 | 0.030 |
Why?
|
| Thrombospondin 1 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Genitalia, Female | 2 | 2007 | 26 | 0.030 |
Why?
|
| Caspases | 1 | 2015 | 132 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 88 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 391 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 128 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 490 | 0.030 |
Why?
|
| Bacteriophage phi X 174 | 2 | 2004 | 11 | 0.030 |
Why?
|
| Drug Design | 2 | 2006 | 154 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 818 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 325 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 454 | 0.030 |
Why?
|
| Weaning | 1 | 2013 | 15 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2012 | 10 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1152 | 0.030 |
Why?
|
| Serpins | 1 | 2012 | 26 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 182 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 445 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 17 | 0.030 |
Why?
|
| Nigeria | 1 | 2011 | 74 | 0.030 |
Why?
|
| Proteome | 1 | 2012 | 132 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 30 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2011 | 188 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 653 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 184 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 249 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 77 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 38 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 160 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 64 | 0.020 |
Why?
|
| Phylogeny | 1 | 2011 | 612 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2007 | 27 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2128 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2005 | 16 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 47 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 562 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 135 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 197 | 0.020 |
Why?
|
| Bacteriolysis | 1 | 2003 | 2 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2003 | 12 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 2003 | 36 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 72 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 11034 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 90 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 131 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 212 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2002 | 1 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2002 | 18 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 108 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2002 | 30 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 35 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 38 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 286 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 53 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 96 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 172 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4012 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 82 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 5035 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 650 | 0.010 |
Why?
|
| Male | 2 | 2013 | 18870 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 6448 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 9642 | 0.010 |
Why?
|